Early tumor shrinkage in patients with metastatic colorectal cancer treated first line with the EGFR inhibitor cetuximab (Erbitux) is associated with prolonged survival, show results reported at the American Society of Clinical Oncology annual meeting (1-5 June 2012; Chicago, USA). Patients with metastatic colorectal cancer taking part in the AIO KRK0104 trial were randomised to capecitabine plus oxaliplatin (CAPOX) or irinotecan (CAPIRI) as first-line treatment...
Realtime Related Tweets
invalid username or userid in get_avatar
donald payne elizabeth berkley mlb 12 the show sabu jenelle evans jenelle evans the voice
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.